A. Fenster and J.C. Lacefield, eds., Ultrasound Imaging and Therapy, Boca Raton, FL: CRC Press, 2015.
M.R. Lowerison, A.F. Chambers, H.S. Leong, N.E. Power, and J.C. Lacefield, “Reduced variability of contrast-enhanced ultrasound perfusion estimates in a patient-derived xenograft tumor model via analysis of speckle statistics,” IEEE International Ultrasonics Symposium, IEEE Ultrason. Symp. Proc., paper P1-C4-2, 2017.
O. Mansour, T.L. Poepping, and J.C. Lacefield, “An improved spread-spectrum method for high-frame-rate color Doppler ultrasound imaging,” IEEE International Ultrasonics Symposium, IEEE Ultrason. Symp. Proc., paper P1-B3-9, 2017.
E. Hysi, L.A. Wirtzfeld, A. Al-Mahrouki, N. Law, M. Elfarnawany, J.C. Lacefield, G.J. Czarnota, and M.C. Kolios, “Implications of tumor oxygenation and blood flow for cancer treatment monitoring using photoacoustic imaging and power Doppler,” IEEE International Ultrasonics Symposium, abstract P1-A7-4, 2017.
M. Lowerison, S. Fedyshyn, S. Prokopec, P. Boutros, A. Chambers, J. Lacefield, N. Power, H. Leong, “Drug resistance consequences of tumor heterogeneity in metastatic renal cell carcinoma using ultra-fast patient derived xenografts and multiregional genomic sequencing,” American Urological Association 2017 Annual Meeting, J. Urol., vol. 197, p. E965, 2017.
M. Lowerison, H.S. Leong, Y. Fedyshyn, A.F. Chambers, J. Lacefield, and N.E. Power, “PDXovo: Ultra-fast in vivo drug sensitivity matrices for renal cell carcinoma patients prior to administration of targeted therapy,” AACR Patient-Derived Cancer Models Meeting, Clin. Cancer Res., vol. 22, no. 16 (suppl.), abstract A09, 2016.